HbA1c, LP — Form D

HbA1c, LP of LOS ANGELES, CA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-11-05. The offering totals $11.5M, of which $4.8M was reported sold. Industry: Other.

Offering

• Filed: 2025-11-05
• Form: D
• Accession: 0002094213-25-000001
• Industry: Other
• Exemptions: 06b, 3C, 3C.1
• Total offering: $11.5M
• Amount sold: $4.8M
• Remaining: $6.7M
• Minimum investment: $25K
• Investors: 15
• Date of first sale: 2025-10-20
• Security types: equity, fund interests
• Revenue range: Decline to Disclose
• SEC file number: 021-563066

Issuer

• Name: HbA1c, LP
• CIK: 0002094213
• Entity type: Limited Partnership
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 5042 WILSHIRE BLVD. #26878, LOS ANGELES, CA, 90036
• Phone: 310-415-9251

Officers, directors & promoters (2)

More

• CIK 2094213 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search